Entrada Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
CGEM
Cullinan Oncology, Inc. |
$10.01 | $1.29 B | -7.16 | 85 | $0 |
CNTA
Centessa Pharmaceuticals plc |
$14.80 | $884.24 M | -6.2 | 76 | $6.85 M |
CRNX
Crinetics Pharmaceuticals, Inc. |
$35.58 | $3.53 B | -11.86 | 290 | $4.01 M |
ELYM
Eliem Therapeutics, Inc. |
$5.11 | $258.33 M | -17.08 | 9 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$27.51 | $1.65 B | -11.47 | 108 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.55 | $243.38 M | -1.59 | 133 | $0 |
GNTA
Genenta Science S.p.A. |
$4.24 | $60.12 M | -4.71 | 14 | $0 |
IRON
Disc Medicine, Inc. |
$57.79 | $967.11 M | -11.82 | 82 | $0 |
LRMR
Larimar Therapeutics, Inc. |
$3.29 | $611.84 M | -9.99 | 42 | $0 |
MOLN
Molecular Partners AG |
$5.38 | $135.05 M | -2.03 | 167 | $7.04 M |
OPT
Opthea Limited |
$3.82 | $214.34 M | -1.04 | 33 | $124,666 |
PEPG
PepGen Inc. |
$2.75 | $537.15 M | -5.11 | 76 | $0 |
PHVS
Pharvaris N.V. |
$16.06 | $843.31 M | -5.8 | 83 | $0 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.35 | $85.40 M | -1.26 | 63 | $0 |
PRDS
Pardes Biosciences, Inc. |
$2.18 | $135.19 M | -1.7 | 57 | $0 |
RLYB
Rallybio Corporation |
$0.89 | $61.34 M | -0.79 | 43 | $0 |
THRD
Third Harmonic Bio, Inc. |
$6.00 | $581.89 M | -18.95 | 51 | $0 |
TYRA
Tyra Biosciences, Inc. |
$15.95 | $1.04 B | -11.7 | 49 | $0 |
VIGL
Vigil Neuroscience, Inc. |
$1.78 | $172.89 M | -2.17 | 64 | $0 |